Download PDF
Dtsch Med Wochenschr 2009; 134(8): 361-364
DOI: 10.1055/s-0028-1124006
Aktuelle Diagnostik & Therapie | Review article
Geburtshilfe, Hämatologie, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York

Hämatologische Neoplasien und solide Tumoren in der Schwangerschaft

Teil 2: Spezielle TherapieHematologic neoplasias and solid tumors in pregnancy Part 2: Specific treatmentH. Popp1 , K. Spiekermann1 , A. Wollenberg2 , C. Spitzweg3 , B. Loehrs4
  • 1Medizinische Klinik und Poliklinik III – Großhadern, Klinikum der Universität München
  • 2Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians Universität München
  • 3Medizinische Klinik und Poliklinik II – Großhadern, Klinikum der Universität München
  • 4Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Großhadern, Klinikum der Universität München
Further Information

Publication History

eingereicht: 6.8.2008

akzeptiert: 2.12.2008

Publication Date:
10 February 2009 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Hämatologische Neoplasien - Solide Tumoren - Schwangerschaft

Keywords

hematological neoplasias - solid tumours - pregnancy

Literatur

  • 1 Abalovich M. et al . Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab. 2007;  92 1-47
    Google Scholar
  • 2 Adelstein S J. Administered radionuclides in pregnancy.  Teratology. 1999;  59 236-239
    Google Scholar
  • 3 Albo D, Wayne J D, Hunt K K. et al . Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer.  Am J Surg. 2001;  182 93-98
    Google Scholar
  • 4 Alexander A. et al . Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant.  J Clin Oncol. 2003;  21 2179-2186
    Google Scholar
  • 5 Ali R, Ozkalemkas F, Ozkocaman V. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature.  Jpn J Clin Oncol. 2004;  34 (4) 215-217
    Google Scholar
  • 6 Aviles A, Diaz-Maqueo J C, Talavera A. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 Children.  Am J Hematol. 1991;  36 243-248
    Google Scholar
  • 7 Breccia M, Cimino G, Mandelli F. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.  Haematologica. 2002;  87 12
    Google Scholar
  • 8 Celo J S, Kim H C, Saidi P. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.  Obstet Gyncol. 1994;  83 808-811
    Google Scholar
  • 9 Cimmino V M, Brown A C, Szocik J F. et al . Allergic reactions to isosulfan blue during sentinel node biopsy – a common event.  Surgery. 2001;  130 439-442
    Google Scholar
  • 10 Delgada-Lamas J L, Garces-Ruiz O M. Acute promyelocytic leukemia in late pregnancy. Successful treatment with all-trans-retinoic acid (ATRA) and chemotherapy.  Hematology. 2000;  4 415-418
    Google Scholar
  • 11 Garbe C. et al . Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.  Melanoma Res. 2008;  18 152-160
    Google Scholar
  • 12 Janni W. Manual Mammakarzinome. Empfehlungen zur Diagnostik, Therapie und Nachsorge. 11. Auflage, ISBN: 978-3-88603-909-9. TUZ München 2007
    Google Scholar
  • 13 Janni W. Treatment of pregnancy associated gynaecological malignancies.  Zentralbl Gynakol. 2006;  128 (3) 129-134
    Google Scholar
  • 14 Kuerer H M, Gwyn K, Theriault R L. Conservative surgery and chemotherapy for breast carcinoma during pregnancy.  Surgery. 2002;  131 108-110
    Google Scholar
  • 15 Loibl S. et al . Breast carcinoma during pregnancy. International recommendations from an expert meeting.  Cancer. 2006;  106 237-246
    Google Scholar
  • 16 Moosa M, Mazzaferri E L. Outcome of differentiated thyroid cancer diagnosed in pregnant women.  J Clin Endocrinol Metab. 1997;  82 2862-2866
    Google Scholar
  • 17 Oehler M K, Wain G V, Brand A. Gynaecological malignancies in pregnancy: a review.  Aust N Z J Obstet Gynaecol. 2003;  43 (6) 414-420
    Google Scholar
  • 18 Pavlidis N, Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer.  Recent Results Cancer Res. 2008;  178 183-194
    Google Scholar
  • 19 Siu B L, Alonzo M R, Fenrich A L. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy.  Int J Gynecol Cancer. 2002;  12 399-402
    Google Scholar
  • 20 Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy.  Blood Rev. 2008;  22 247-259
    Google Scholar
  • 21 Steenvoorde P, Pauwels E K, Harding L K. et al . Diagnostic nuclear medicine and risk for the fetus.  Eur J Nucl Med. 1998;  25 193-199
    Google Scholar
  • 22 Timins J K. Radiation during pregnancy.  N J Med. 2001;  98 29-33
    Google Scholar
  • 23 Watson W J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnions.  Obstet Gynecol. 2005;  105 642
    Google Scholar
  • 24 Wyatt R M, Dale R G. The effect of delay in radiotherapy treatment on tumour control.  Phys Med Biol. 2003;  48 139-155
    Google Scholar

Dr. med. Henning Popp

Medizinische Klinik und Poliklinik III, Klinikum der Universität München – Großhadern

Marchioninistr. 15

81377 München

Email: Henning.Popp@med.uni-muenchen.de